Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer February 23, 2023February 23, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: FDA Approves Tissue-Based NGS Companion Diagnostic…Mass spectrometry technology contributed to the…Roche’s VENTANA PD-L1 (SP263) Assay receives FDA…Roche receives FDA approval for first companion…Roche launches three respiratory test panels on…Roche launches PRAME (EPR20330) Antibody to identify…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
